Back to MORGAN STANLEY MORGAN STANLEY

AVIRAVIR
Showing 8 of 9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in ATEA PHARMACEUTICALS INC

MORGAN STANLEY holds 719,514 shares of AVIR (ATEA PHARMACEUTICALS INC), worth $3.3M as of 2026-Q2. The position was decreased (-1.6% shares). AVIR represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$3.3M

Current Shares

719,514

Total Value Change

+$1.7M

Total Shares Change

+230,615

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
719,514
-1.6%
$3.3M0.0%$4.65
0
2026-Q1
Increased
731,020
+11.4%
$3.9M0.0%$4.82
30
2025-Q4
Increased
656,075
+45.6%
$2.3M0.0%$3.55
35
2025-Q3
Decreased
450,564
-17.2%
$1.3M0.0%$2.92
0
2025-Q2
Increased
544,268
+19.5%
$2M0.0%$3.45
31
2025-Q1
Decreased
455,344
-19.7%
$1.4M0.0%$2.93
0
2024-Q4
Increased
567,040
+16.0%
$1.9M0.0%$3.33
30
2024-Q3
Increased
488,899
+33.0%
$1.6M0.0%$3.44
33

Other major holders of AVIR: RA CAPITAL MANAGEMENT, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used